We are live on
!
Find out more
Eagle Capital Management (New York) Portfolio holdings
AUM
$29.8B
1-Year Est. Return
12.13%
This Fund
S&P 500
This Quarter
Est. Return
-13.62%
1 Year Est. Return
+12.13%
3 Year Est. Return
+86.1%
5 Year Est. Return
+93.52%
10 Year Est. Return
+413.56%
AUM
$24.5B
AUM Growth
-$4.65B
(-16%)
Cap. Flow
-$537M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
58.52%
Holding
64
New
5
Increased
15
Reduced
26
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$601M |
| 2 |
Marriott International
MAR
|
+$395M |
| 3 |
Hilton Worldwide
HLT
|
+$283M |
| 4 |
GE Aerospace
GE
|
+$238M |
| 5 |
Citigroup
C
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$762M |
| 2 |
JPMorgan Chase
JPM
|
+$653M |
| 3 |
United Parcel Service
UPS
|
+$432M |
| 4 |
Aon
AON
|
+$392M |
| 5 |
Ecolab
ECL
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 30.04% |
| 2 | Financials | 28.29% |
| 3 | Consumer Discretionary | 18.06% |
| 4 | Technology | 12.77% |
| 5 | Healthcare | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
First Citizens BancShares
FCNCA
$25.3B
| $588K | ﹤0.01% |
1,560
| – | – |
|
|
BNY
52
Bank of New York Mellon
BNY
$107B
| $565K | ﹤0.01% |
12,000
| – | – |
|
53
American International
AIG
$41.3B
| $520K | ﹤0.01% |
13,200
| – | – |
|
54
Liberty Latin America Class C
LILAK
$1.64B
| $514K | ﹤0.01% |
41,234
-1,895,595
| -98% | -$29.2M |
|
55
ConocoPhillips
COP
$141B
| $349K | ﹤0.01% |
5,600
| – | – |
|
56
IBM
IBM
$224B
| $307K | ﹤0.01% |
2,824
| – | – |
|
|
NFX
57
DELISTED
Newfield Exploration
NFX
| $233K | ﹤0.01% |
15,900
| – | – |
|
|
NTRP
58
DELISTED
Neurotrope, Inc. Common
NTRP
| $213K | ﹤0.01% |
59,745
| – | – |
|
59
APA Corp
APA
$13.2B
| – | – |
-4,300
| Closed | -$205K |
|
60
Alibaba
BABA
$308B
| – | – |
-3,650
| Closed | -$601K |
|
61
Bausch Health
BHC
$2.34B
| – | – |
-8,600
| Closed | -$221K |
|
|
PX
62
DELISTED
Praxair Inc
PX
| – | – |
-6,280
| Closed | -$1.01M |
|
|
ASCMA
63
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| – | – |
-45,423
| Closed | -$80K |
|
Similar funds
Eagle Capital Management (New York)'s Q4 2018 Portfolio in Review
As of Q4 2018, Eagle Capital Management (New York) held 64 positions worth $24.5B, down 16% from $29.1B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Eagle Capital Management (New York)'s Q4 2018 filing shows 5 new, 15 increased, 26 reduced and 6 closed positions. Its largest new stake was Hilton Worldwide: 3,919,712 shares worth $281M. The largest sale was Thermo Fisher Scientific, an estimated $762M.
By sector, the portfolio is most concentrated in Communication Services at 30% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Eagle Capital Management (New York)'s largest Q4 2018 buy was Hilton Worldwide: 3,919,712 shares worth $281M.
- Eagle Capital Management (New York) added most to Goldman Sachs in Q4 2018, an estimated $601M increase.
- Eagle Capital Management (New York)'s biggest Q4 2018 reduction was Thermo Fisher Scientific, cutting an estimated $762M.
- Eagle Capital Management (New York) fully exited Praxair Inc in Q4 2018, selling an estimated $1.01M.
- Eagle Capital Management (New York)'s ten largest holdings make up 59% of its $24.5B portfolio in Q4 2018.
- Eagle Capital Management (New York) opened 5 new positions and closed 6 in Q4 2018.
- Eagle Capital Management (New York)'s portfolio value fell 16% quarter-over-quarter to $24.5B.
Based on Eagle Capital Management (New York)'s 13F filing for Q4 2018, filed 14 Feb 2019.